Global Immunogenicity Testing Service Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256608

Publication Date:

March 3, 2025

Pages:

149

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Immunogenicity Testing Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Immunogenicity testing service refers to a laboratory service that evaluates the immune response of an individual to a specific substance, such as a drug or vaccine. This testing is performed to determine the likelihood of an immune response, including the production of antibodies, against the substance being tested. Immunogenicity testing is often conducted during the development of new drugs or vaccines to assess their safety and effectiveness. It can also be used in clinical settings to monitor the immune response of patients receiving certain treatments. The results of immunogenicity testing can help guide treatment decisions and ensure patient safety.
United States market for Immunogenicity Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Immunogenicity Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Immunogenicity Testing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Immunogenicity Testing Service players cover Profacgen, Charles River Laboratories, Pacific BioLabs, Celerion, Precision Medicine Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淚mmunogenicity Testing Service Industry Forecast鈥� looks at past sales and reviews total world Immunogenicity Testing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Immunogenicity Testing Service sales for 2025 through 2031. With Immunogenicity Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunogenicity Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Immunogenicity Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunogenicity Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Immunogenicity Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunogenicity Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunogenicity Testing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunogenicity Testing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
A Single Assay
Two Assays
Segmentation by Application:
Enterprise
Factory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Profacgen
Charles River Laboratories
Pacific BioLabs
Celerion
Precision Medicine Group
BioAgilytix
FyoniBio
Chimera Biotec
Alcyomics
ProImmune
Creative Biolabs
SGS
Eurofins Scientific
Syrinx Bioanalytics
Pharmaron
NorthEast BioAnalytical Laboratories
Svar Life Science
CellCarta
BioGenes
EpiVax
ImmunXperts

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunogenicity Testing Service Market Size (2020-2031)
2.1.2 Immunogenicity Testing Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Immunogenicity Testing Service by Country/Region (2020, 2024 & 2031)
2.2 Immunogenicity Testing Service Segment by Type
2.2.1 A Single Assay
2.2.2 Two Assays
2.3 Immunogenicity Testing Service Market Size by Type
2.3.1 Immunogenicity Testing Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Immunogenicity Testing Service Market Size Market Share by Type (2020-2025)
2.4 Immunogenicity Testing Service Segment by Application
2.4.1 Enterprise
2.4.2 Factory
2.5 Immunogenicity Testing Service Market Size by Application
2.5.1 Immunogenicity Testing Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Immunogenicity Testing Service Market Size Market Share by Application (2020-2025)
3 Immunogenicity Testing Service Market Size by Player
3.1 Immunogenicity Testing Service Market Size Market Share by Player
3.1.1 Global Immunogenicity Testing Service Revenue by Player (2020-2025)
3.1.2 Global Immunogenicity Testing Service Revenue Market Share by Player (2020-2025)
3.2 Global Immunogenicity Testing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immunogenicity Testing Service by Region
4.1 Immunogenicity Testing Service Market Size by Region (2020-2025)
4.2 Global Immunogenicity Testing Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immunogenicity Testing Service Market Size Growth (2020-2025)
4.4 APAC Immunogenicity Testing Service Market Size Growth (2020-2025)
4.5 Europe Immunogenicity Testing Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Immunogenicity Testing Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Immunogenicity Testing Service Market Size by Country (2020-2025)
5.2 Americas Immunogenicity Testing Service Market Size by Type (2020-2025)
5.3 Americas Immunogenicity Testing Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunogenicity Testing Service Market Size by Region (2020-2025)
6.2 APAC Immunogenicity Testing Service Market Size by Type (2020-2025)
6.3 APAC Immunogenicity Testing Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immunogenicity Testing Service Market Size by Country (2020-2025)
7.2 Europe Immunogenicity Testing Service Market Size by Type (2020-2025)
7.3 Europe Immunogenicity Testing Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunogenicity Testing Service by Region (2020-2025)
8.2 Middle East & Africa Immunogenicity Testing Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Immunogenicity Testing Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immunogenicity Testing Service Market Forecast
10.1 Global Immunogenicity Testing Service Forecast by Region (2026-2031)
10.1.1 Global Immunogenicity Testing Service Forecast by Region (2026-2031)
10.1.2 Americas Immunogenicity Testing Service Forecast
10.1.3 APAC Immunogenicity Testing Service Forecast
10.1.4 Europe Immunogenicity Testing Service Forecast
10.1.5 Middle East & Africa Immunogenicity Testing Service Forecast
10.2 Americas Immunogenicity Testing Service Forecast by Country (2026-2031)
10.2.1 United States Market Immunogenicity Testing Service Forecast
10.2.2 Canada Market Immunogenicity Testing Service Forecast
10.2.3 Mexico Market Immunogenicity Testing Service Forecast
10.2.4 Brazil Market Immunogenicity Testing Service Forecast
10.3 APAC Immunogenicity Testing Service Forecast by Region (2026-2031)
10.3.1 China Immunogenicity Testing Service Market Forecast
10.3.2 Japan Market Immunogenicity Testing Service Forecast
10.3.3 Korea Market Immunogenicity Testing Service Forecast
10.3.4 Southeast Asia Market Immunogenicity Testing Service Forecast
10.3.5 India Market Immunogenicity Testing Service Forecast
10.3.6 Australia Market Immunogenicity Testing Service Forecast
10.4 Europe Immunogenicity Testing Service Forecast by Country (2026-2031)
10.4.1 Germany Market Immunogenicity Testing Service Forecast
10.4.2 France Market Immunogenicity Testing Service Forecast
10.4.3 UK Market Immunogenicity Testing Service Forecast
10.4.4 Italy Market Immunogenicity Testing Service Forecast
10.4.5 Russia Market Immunogenicity Testing Service Forecast
10.5 Middle East & Africa Immunogenicity Testing Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Immunogenicity Testing Service Forecast
10.5.2 South Africa Market Immunogenicity Testing Service Forecast
10.5.3 Israel Market Immunogenicity Testing Service Forecast
10.5.4 Turkey Market Immunogenicity Testing Service Forecast
10.6 Global Immunogenicity Testing Service Forecast by Type (2026-2031)
10.7 Global Immunogenicity Testing Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Immunogenicity Testing Service Forecast
11 Key Players Analysis
11.1 Profacgen
11.1.1 Profacgen Company Information
11.1.2 Profacgen Immunogenicity Testing Service Product Offered
11.1.3 Profacgen Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Profacgen Main Business Overview
11.1.5 Profacgen Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Immunogenicity Testing Service Product Offered
11.2.3 Charles River Laboratories Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Pacific BioLabs
11.3.1 Pacific BioLabs Company Information
11.3.2 Pacific BioLabs Immunogenicity Testing Service Product Offered
11.3.3 Pacific BioLabs Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pacific BioLabs Main Business Overview
11.3.5 Pacific BioLabs Latest Developments
11.4 Celerion
11.4.1 Celerion Company Information
11.4.2 Celerion Immunogenicity Testing Service Product Offered
11.4.3 Celerion Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Celerion Main Business Overview
11.4.5 Celerion Latest Developments
11.5 Precision Medicine Group
11.5.1 Precision Medicine Group Company Information
11.5.2 Precision Medicine Group Immunogenicity Testing Service Product Offered
11.5.3 Precision Medicine Group Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Precision Medicine Group Main Business Overview
11.5.5 Precision Medicine Group Latest Developments
11.6 BioAgilytix
11.6.1 BioAgilytix Company Information
11.6.2 BioAgilytix Immunogenicity Testing Service Product Offered
11.6.3 BioAgilytix Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BioAgilytix Main Business Overview
11.6.5 BioAgilytix Latest Developments
11.7 FyoniBio
11.7.1 FyoniBio Company Information
11.7.2 FyoniBio Immunogenicity Testing Service Product Offered
11.7.3 FyoniBio Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 FyoniBio Main Business Overview
11.7.5 FyoniBio Latest Developments
11.8 Chimera Biotec
11.8.1 Chimera Biotec Company Information
11.8.2 Chimera Biotec Immunogenicity Testing Service Product Offered
11.8.3 Chimera Biotec Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Chimera Biotec Main Business Overview
11.8.5 Chimera Biotec Latest Developments
11.9 Alcyomics
11.9.1 Alcyomics Company Information
11.9.2 Alcyomics Immunogenicity Testing Service Product Offered
11.9.3 Alcyomics Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Alcyomics Main Business Overview
11.9.5 Alcyomics Latest Developments
11.10 ProImmune
11.10.1 ProImmune Company Information
11.10.2 ProImmune Immunogenicity Testing Service Product Offered
11.10.3 ProImmune Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 ProImmune Main Business Overview
11.10.5 ProImmune Latest Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Information
11.11.2 Creative Biolabs Immunogenicity Testing Service Product Offered
11.11.3 Creative Biolabs Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Creative Biolabs Main Business Overview
11.11.5 Creative Biolabs Latest Developments
11.12 SGS
11.12.1 SGS Company Information
11.12.2 SGS Immunogenicity Testing Service Product Offered
11.12.3 SGS Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 SGS Main Business Overview
11.12.5 SGS Latest Developments
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Information
11.13.2 Eurofins Scientific Immunogenicity Testing Service Product Offered
11.13.3 Eurofins Scientific Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Eurofins Scientific Main Business Overview
11.13.5 Eurofins Scientific Latest Developments
11.14 Syrinx Bioanalytics
11.14.1 Syrinx Bioanalytics Company Information
11.14.2 Syrinx Bioanalytics Immunogenicity Testing Service Product Offered
11.14.3 Syrinx Bioanalytics Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Syrinx Bioanalytics Main Business Overview
11.14.5 Syrinx Bioanalytics Latest Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Information
11.15.2 Pharmaron Immunogenicity Testing Service Product Offered
11.15.3 Pharmaron Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Pharmaron Main Business Overview
11.15.5 Pharmaron Latest Developments
11.16 NorthEast BioAnalytical Laboratories
11.16.1 NorthEast BioAnalytical Laboratories Company Information
11.16.2 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Product Offered
11.16.3 NorthEast BioAnalytical Laboratories Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 NorthEast BioAnalytical Laboratories Main Business Overview
11.16.5 NorthEast BioAnalytical Laboratories Latest Developments
11.17 Svar Life Science
11.17.1 Svar Life Science Company Information
11.17.2 Svar Life Science Immunogenicity Testing Service Product Offered
11.17.3 Svar Life Science Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Svar Life Science Main Business Overview
11.17.5 Svar Life Science Latest Developments
11.18 CellCarta
11.18.1 CellCarta Company Information
11.18.2 CellCarta Immunogenicity Testing Service Product Offered
11.18.3 CellCarta Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 CellCarta Main Business Overview
11.18.5 CellCarta Latest Developments
11.19 BioGenes
11.19.1 BioGenes Company Information
11.19.2 BioGenes Immunogenicity Testing Service Product Offered
11.19.3 BioGenes Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 BioGenes Main Business Overview
11.19.5 BioGenes Latest Developments
11.20 EpiVax
11.20.1 EpiVax Company Information
11.20.2 EpiVax Immunogenicity Testing Service Product Offered
11.20.3 EpiVax Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 EpiVax Main Business Overview
11.20.5 EpiVax Latest Developments
11.21 ImmunXperts
11.21.1 ImmunXperts Company Information
11.21.2 ImmunXperts Immunogenicity Testing Service Product Offered
11.21.3 ImmunXperts Immunogenicity Testing Service Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 ImmunXperts Main Business Overview
11.21.5 ImmunXperts Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂